Literature DB >> 10972291

SLAM (CDw150) is a cellular receptor for measles virus.

H Tatsuo1, N Ono, K Tanaka, Y Yanagi.   

Abstract

Measles virus continues to be a major killer of children, claiming roughly one million lives a year. Measles virus infection causes profound immunosuppression, which makes measles patients susceptible to secondary infections accounting for high morbidity and mortality. The Edmonston strain of measles virus, and vaccine strains derived from it, use as a cellular receptor human CD46 (refs 3, 4), which is expressed on all nucleated cells; however, most clinical isolates of measles virus cannot use CD46 as a receptor. Here we show that human SLAM (signalling lymphocyte-activation molecule; also known as CDw150), a recently discovered membrane glycoprotein expressed on some T and B cells, is a cellular receptor for measles virus, including the Edmonston strain. Transfection with a human SLAM complementary DNA enables non-susceptible cell lines to bind measles virus, support measles virus replication and develop cytopathic effects. The distribution of SLAM on various cell lines is consistent with their susceptibility to clinical isolates of measles virus. The identification of SLAM as a receptor for measles virus opens the way to a better understanding of the pathogenesis of measles virus infection, especially the immunosuppression induced by measles virus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10972291     DOI: 10.1038/35022579

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  424 in total

1.  Comparison of the neuropathogenicity of two SSPE sibling viruses of the Osaka-2 strain isolated with Vero and B95a cells.

Authors:  Nobuhisa Ito; Minoru Ayata; Masashi Shingai; Kyoko Furukawa; Toshiyuki Seto; Isamu Matsunaga; Michinari Muraoka; Hisashi Ogura
Journal:  J Neurovirol       Date:  2002-02       Impact factor: 2.643

2.  Recombinant wild-type and edmonston strain measles viruses bearing heterologous H proteins: role of H protein in cell fusion and host cell specificity.

Authors:  Kaoru Takeuchi; Makoto Takeda; Naoko Miyajima; Fumio Kobune; Kiyoshi Tanabayashi; Masato Tashiro
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer.

Authors:  Evanthia Galanis; Pamela J Atherton; Matthew J Maurer; Keith L Knutson; Sean C Dowdy; William A Cliby; Paul Haluska; Harry J Long; Ann Oberg; Ileana Aderca; Matthew S Block; Jamie Bakkum-Gamez; Mark J Federspiel; Stephen J Russell; Kimberly R Kalli; Gary Keeney; Kah Whye Peng; Lynn C Hartmann
Journal:  Cancer Res       Date:  2014-11-14       Impact factor: 12.701

4.  Measles virus glycoprotein complexes preassemble intracellularly and relax during transport to the cell surface in preparation for fusion.

Authors:  Melinda A Brindley; Sukanya Chaudhury; Richard K Plemper
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

5.  Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model.

Authors:  Sompong Vongpunsawad; Numan Oezgun; Werner Braun; Roberto Cattaneo
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

6.  DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safety.

Authors:  Katrin Friedrich; Jan Rh Hanauer; Steffen Prüfer; Robert C Münch; Iris Völker; Christodoulos Filippis; Christian Jost; Kay-Martin Hanschmann; Roberto Cattaneo; Kah-Whye Peng; Andreas Plückthun; Christian J Buchholz; Klaus Cichutek; Michael D Mühlebach
Journal:  Mol Ther       Date:  2013-02-05       Impact factor: 11.454

7.  Characterization of measles virus strains causing SSPE: a study of 11 cases.

Authors:  L Jin; S Beard; R Hunjan; D W G Brown; E Miller
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

8.  A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAM- and CD46-independent mechanism.

Authors:  Makoto Takeda; Maino Tahara; Takao Hashiguchi; Takeshi A Sato; Fumiaki Jinnouchi; Shoko Ueki; Shinji Ohno; Yusuke Yanagi
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

9.  Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment.

Authors:  Jayson Hardcastle; Lisa Mills; Courtney S Malo; Fang Jin; Cheyne Kurokawa; Hirosha Geekiyanage; Mark Schroeder; Jann Sarkaria; Aaron J Johnson; Evanthia Galanis
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

10.  Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling.

Authors:  Karen Bieback; Egil Lien; Ingo M Klagge; Elita Avota; Jürgen Schneider-Schaulies; W Paul Duprex; Herrmann Wagner; Carsten J Kirschning; Volker Ter Meulen; Sibylle Schneider-Schaulies
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.